Literature DB >> 23132690

Is Helicobacter pylori good or bad?

S Mishra1.   

Abstract

Helicobacter pylori remains a controversial organism with regards to humans, with its epidemiology still being unclear nearly two decades after its discovery. The association between H. pylori infection and subsequent development of chronic active gastritis, peptic ulcer disease, gastric cell carcinoma, and B cell mucosa-associated lymphoid tissue (MALT) lymphoma has been well established. Current studies, however, suggest that fewer than 20 % of all infected patients will develop any consequences from their infection. Hence, should the infection be considered a disease not at all or, on the contrary, is the microorganism harmful in only some circumstances? This article attempts to weigh the currently available evidence supporting that H. pylori may be good and not always bad.

Entities:  

Mesh:

Year:  2012        PMID: 23132690     DOI: 10.1007/s10096-012-1773-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection?

Authors:  M Hobsley; F I Tovey
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

3.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.

Authors:  W H Chow; M J Blaser; W J Blot; M D Gammon; T L Vaughan; H A Risch; G I Perez-Perez; J B Schoenberg; J L Stanford; H Rotterdam; A B West; J F Fraumeni
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

5.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 6.  Helicobacter pylori in health and disease.

Authors:  Timothy L Cover; Martin J Blaser
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

7.  Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US.

Authors:  Tanuja Rastogi; Susan Devesa; Punam Mangtani; Aleyamma Mathew; Nicola Cooper; Roy Kao; Rashmi Sinha
Journal:  Int J Epidemiol       Date:  2007-12-19       Impact factor: 7.196

Review 8.  Helicobacter pylori in peptic ulcer: have Koch's postulates been fulfilled?

Authors:  B J Marshall
Journal:  Ann Med       Date:  1995-10       Impact factor: 4.709

9.  Prevalence of Helicobacter pylori in asymptomatic subjects--a nested PCR based study.

Authors:  Shrutkirti Mishra; Varsha Singh; G R K Rao; V K Dixit; A K Gulati; Gopal Nath
Journal:  Infect Genet Evol       Date:  2008-08-14       Impact factor: 3.342

Review 10.  Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.

Authors:  R J Hopkins; L S Girardi; E A Turney
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  18 in total

Review 1.  Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma.

Authors:  Rong-Guang Zhang; Guang-Cai Duan; Qing-Tang Fan; Shuai-Yin Chen
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 3.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  New transport medium for cultural recovery of Helicobacter pylori.

Authors:  Luigina Cellini; Emanuela Di Campli; Soraya Di Bartolomeo; Lucinda Janete Bessa; Marina Baffoni; Mara Di Giulio
Journal:  J Clin Microbiol       Date:  2014-10-15       Impact factor: 5.948

Review 5.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

Review 6.  Helicobacter pylori infection: new pathogenetic and clinical aspects.

Authors:  Krisztina Hagymási; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Frequency of iron deficiency anemia (IDA) among patients with Helicobacter pylori infection.

Authors:  Adeel Rahat; Lubna Kamani
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

8.  Binding of the Helicobacter pylori OipA causes apoptosis of host cells via modulation of Bax/Bcl-2 levels.

Authors:  Omid Teymournejad; Ashraf Mohabati Mobarez; Zuhair Mohammad Hassan; Amin Talebi Bezmin Abadi
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

9.  In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori.

Authors:  Angela Filocamo; Carlo Bisignano; Nadia Ferlazzo; Santa Cirmi; Giuseppina Mandalari; Michele Navarra
Journal:  BMC Complement Altern Med       Date:  2015-07-30       Impact factor: 3.659

10.  Severe Anemia and Helicobacter Pylori Infection in school age Children; A case reports.

Authors:  Sh Gheibi; M Noroozi; S Hejazi; M Karamyyar; H Farrokh-Eslamlou
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.